BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 337 filers reported holding BIONTECH SE in Q3 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,489,799 | -39.2% | 179,398 | -39.6% | 0.04% | -37.1% |
| Q2 2023 | $32,042,366 | +1294.8% | 296,881 | +1509.9% | 0.07% | +1300.0% |
| Q1 2023 | $2,297,195 | -89.0% | 18,441 | -86.8% | 0.01% | -84.8% |
| Q4 2022 | $20,973,116 | +15.9% | 139,616 | +4.0% | 0.03% | +17.9% |
| Q3 2022 | $18,096,000 | -3.9% | 134,192 | +6.3% | 0.03% | +55.6% |
| Q2 2022 | $18,825,000 | -64.6% | 126,269 | -59.5% | 0.02% | -35.7% |
| Q1 2022 | $53,234,000 | -46.1% | 312,118 | -18.6% | 0.03% | -68.5% |
| Q4 2021 | $98,835,000 | -9.1% | 383,362 | -3.8% | 0.09% | +8.5% |
| Q3 2021 | $108,737,000 | +51.4% | 398,328 | +24.1% | 0.08% | +28.1% |
| Q2 2021 | $71,836,000 | +456.0% | 320,868 | +171.2% | 0.06% | +481.8% |
| Q1 2021 | $12,920,000 | +4927.2% | 118,326 | +3655.2% | 0.01% | – |
| Q4 2020 | $257,000 | – | 3,151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |